Michael Hauptmann
Overview
Explore the profile of Michael Hauptmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
4898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheibner H, Gesell D, Hauptmann M, Heinze M, Horenkamp-Sonntag D, Koller D, et al.
BMJ Open
. 2025 Feb;
15(2):e092210.
PMID: 39956603
Introduction: Care for people living with dementia is both important and complex, and there is evidence of large regional variations in the quality of care. This study protocol describes design,...
2.
Caramenti L, Wolowiec P, Kedzierawski P, Gozdz S, Buchali A, Hauptmann M, et al.
Radiat Res
. 2025 Jan;
203(2):107-114.
PMID: 39805311
The role of genetics in susceptibility to radiotherapy-induced toxicities is unclear. A strong impact of genetics should cause correlated toxicities in patients with metachronous double radiotherapy. We ascertained information about...
3.
Roberti S, Russell N, Pfeiffer R, Krul I, De Vathaire F, Veres C, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39793858
Purpose: To contrast breast radiation exposure from chest radiation therapy (RT) between 2006 and 2021 with those given between 1965 and 1997, and to compare breast cancer (BC) risk 25...
4.
Roberti S, van Leeuwen F, Diallo I, De Vathaire F, Schaapveld M, Leisenring W, et al.
J Natl Cancer Inst
. 2024 Nov;
PMID: 39485483
Background: While female survivors of Hodgkin lymphoma (HL) have an increased risk of breast cancer (BC), no BC risk prediction model is available. We developed such models incorporating mean radiation...
5.
Caramenti L, Breckow J, Hildebrandt G, Drexler H, Volkmer B, Hauptmann M
J Radiol Prot
. 2024 Sep;
PMID: 39326441
Cancer of the skin represents a challenge for radiological protection, as it is very common and involves the largest organ of the human body, which is exposed to environmental stress,...
6.
Duinkerken C, Chiodo S, Hueniken K, Hauptmann M, Jozwiak K, Cheng D, et al.
Cancer Med
. 2024 Aug;
13(16):e7465.
PMID: 39159054
Background: Concomitant high-dose cisplatin with radiotherapy is commonly used for treating head and neck squamous cell carcinoma (HNSCC). Cisplatin, often used with radiotherapy, is known for causing irreversible sensorineural hearing...
7.
Little M, Bazyka D, Berrington de Gonzalez A, Brenner A, Chumak V, Cullings H, et al.
Radiat Res
. 2024 Jul;
202(2):432-487.
PMID: 39021204
In this article we review the history of key epidemiological studies of populations exposed to ionizing radiation. We highlight historical and recent findings regarding radiation-associated risks for incidence and mortality...
8.
Mantke R, Schneider C, von Ruesten A, Hauptmann M
Int J Surg
. 2024 Jun;
110(10):6493-6500.
PMID: 38935125
Objective: To compare the survival of palliative stage IV colorectal cancer patients selected for primary tumor resection and systemic treatment (PTR+SYST) to patients with systemic treatment only (SYST). Background: About...
9.
Rebitschek F, Eisenmann Y, Krippner L, Neugebauer E, Schirren C, Schnuppe K, et al.
Psychol Health
. 2024 Jan;
:1-27.
PMID: 38251635
To enable future open-air festivals during a pandemic, model festivals tested restricted access and behavioural rules to prevent SARS-CoV-2 transmissions. However, the uptake of health-protective measures depends on informed acceptance,...
10.
Wang Y, Dackus G, Rosenberg E, Cornelissen S, de Boo L, Broeks A, et al.
BMC Med
. 2024 Jan;
22(1):9.
PMID: 38191387
Background: Due to the abundant usage of chemotherapy in young triple-negative breast cancer (TNBC) patients, the unbiased prognostic value of BRCA1-related biomarkers in this population remains unclear. In addition, whether...